No Data
No Data
No Data
No Data
No Data
Trending Industry Today: TIGERMED Leads Gains In Pharmaceutical Outsourcing/contract Research Organization(cro Concept) Stocks
April 26th - The industry of $Pharmaceutical Outsourcing/contract Research Organization(cro Concept)(BK1261.HK)$ is trending higher today with 8 constituents up and TIGERMED leading Gains.$TIGERMED(03
moomoo NewsApr 26 03:50 ET
Changes in Hong Kong stocks | Tiger Pharmaceuticals (03347) rose more than 8% to lead CRO concept stocks, reports say the national level is expected to introduce an action plan for the biological manufacturing industry in the near future
CRO concept stocks increased their gains in the afternoon. As of press release, Tiger Pharmaceuticals (03347) rose 8.39% to HK$33.6; Kanglong Chemical (03759) rose 7.16% to HK$9.43; Pharmaceutical Biotech (02269) rose 6.75% to HK$13.6; and Pharmaceuticals (02359) rose 4.74% to HK$35.35.
Zhitong FinanceApr 26 02:28 ET
On April 23, Yao Ming Biotech spent HK$24.884,200 to buy back 1.905 million shares
Pharmaceutical Biotech (02269) announced that on April 23, 2024, the company spent HK$24.884,200 to repurchase 1.905 million shares at a repurchase price of HK$12.92-13.32 per share.
新浪港股Apr 23 21:01 ET
Pharmaceutical Biotech (02269) spent HK$248.842 million to buy back 1.905 million shares on April 23
Yao Ming Biotech (02269) announced that on April 23, 2024, the company spent 24.8842 million...
Zhitong FinanceApr 23 09:24 ET
On April 22, Yao Ming Biotech spent HK$1991215 million to buy back 1.55 million shares
Pharmaceutical Biotech (02269) announced that on April 22, 2024, it spent HK$1991215 million to repurchase 1.55 million shares.
新浪港股Apr 22 21:12 ET
Pharmaceutical Biotech (02269) spent HK$19912,150 to buy back 1.55 million shares on April 22
Pharmaceutical Biotech (02269) announced that on April 22, 2024, it cost HK$19912,150 to repurchase 15...
Zhitong FinanceApr 22 08:54 ET
No Data
No Data